Market Trends FDA accepts Verastem NDA for priority review, stock jumps 20% (update)By admin8996erT0allDecember 31, 2024 GrandbrothersVerastem (NASDAQ:VSTM) stock shot up 20% in after-hours trading on news that the FDA has accepted for priority review the…
Market Trends PTC Therapeutics submits NDA for Friedreich ataxia treatment vatiquinoneBy admin8996erT0allDecember 19, 2024 Shidlovski PTC Therapeutics (NASDAQ:PTCT) has submitted a New Drug Application to the U.S. FDA seeking approval of its Friedreich ataxia…